Surgery – Means for introducing or removing material from body for... – Gas application
Patent
1993-03-24
1996-07-16
Green, Randall L.
Surgery
Means for introducing or removing material from body for...
Gas application
604 26, 604 48, A61M 3700
Patent
active
055362419
ABSTRACT:
Methods and devices for using nitric oxide (NO) to decrease or prevent the contraction of a smooth muscle in a non-respiratory-tract organ of an animal, the organ being one which contains or is surrounded by a biological fluid which is not blood, which method includes the step of introducing an effective amount of NO into the fluid.
REFERENCES:
patent: 3785377 (1974-01-01), Jorgensen
patent: 4010897 (1977-03-01), Treharne et al.
patent: 4287040 (1981-09-01), Alamaro
patent: 4297123 (1981-10-01), Wyse et al.
patent: 4336798 (1982-06-01), Beran
patent: 4534343 (1985-08-01), Nowacki et al.
patent: 4592348 (1986-06-01), Waters et al.
patent: 4667668 (1987-05-01), Wetterlin
patent: 4852561 (1989-08-01), Sperry
patent: 4877589 (1989-10-01), O'Hara
patent: 4915915 (1990-04-01), Treharne et al.
patent: 4954526 (1990-09-01), Keefer
patent: 5098376 (1992-03-01), Berry et al.
patent: 5155137 (1992-10-01), Keefer et al.
patent: 5208233 (1993-05-01), Keefer et al.
patent: 5396882 (1995-03-01), Zapol
patent: 5427797 (1995-06-01), Frostell et al.
Blomqvist et al., Inhaled Nitric Oxide (NO): A Selective Pulmonary Vasodilator Reversing Human Hypoxic Pulmonary Vasoconstriction (HPV), Circulation 84:361, 1991.
Desai et al., Involvement of Nitric Oxide in the Reflex Relaxation of the Stomach to Accommodate food or Fluid, Nature 351:477, 1991.
Donahoe et al., Production of O.sub.3, NO, and N.sub.2 O in a Pulsed Discharge at 1 Atm, Ind. Eng. Chem. 16:208-215, 1977.
Fractacci et al. Inhaled Nitric Oxide, Anesthesiology 75:990-999, 1991.
Pepke-Zaba et al., Inhaled Nitric Oxide as a Cause of Selective Pulmonary Vasodilation in Pulmonary Hypertension, The Lancet 338:1173-1174, 1991.
Rimar et al., Prolonged Duration of Inhaled Nitric Oxide Induced Vasodilation in Perfused Rabbit Lungs Circulation 84:362, 1991.
Roberts, Jr. et al., Inhaled Nitric Oxide (NO): A Selective Pulmonary Vasodilator for the Treatment of Persistent Pulmonary Hypertension of the Newborn (PPHN), Circulation 84:1279, 1991.
Dupuy et al., Bronchodilator Action of Inhaled Nitric Oxide in Guinea Pigs, J. clin. Invest. 90:421-428, 1992.
Kacmarek et al., Nitric Oxide as a Bronchodilator in Methacholilne Induced Bronchospasm in Mild Asthmatics, 1993 ALA/ATS International Conference, May 16-19, 1993, San Francisco, CA #21556 (Abstract).
Messent et al., The Pulmonary Physician and Critical Care, Thorax 47:651-656, 1992.
Swami et al., the Pulmonary Physician and Critical Care, Thorax 47:555-562, 1992.
Frostell, Md,PhD et al., Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator Reversing Hypoxic Pulmonary Vasoconstriction, Circulation 83:2038-2047, 1991.
Dalby et al., Comparison of Output Particle Size Distribution from Pressurized Aerosols Formulated as Solutions or Suspensions, Pharmac. Re. 5:36-39, 1988.
Buga et al., Endothelium-Derived Nitric Oxide Relaxes Nonvascular Smooth Muscle, European J. of Pharmc. 161:61-72, 1989.
Ishii et al., A Simple and Sensitive Bioassay Method for Detection of EDRF with RFL-6 Rat Lung Fibroblasts, Am. J. Physiol. 261:H598-H603, 1991.
Stuart-Smith et al., Epithelium, contractile Tone, and Responses to Relaxing Agonists in Canine Bronchi, J. Appl. Physiol. 69:678-685, 1990.
Suzuki et al., The Relationship Between Tissue Levels of Cyclic GMP and Tracheal Smooth Muscle Relaxation in the Guinea-Pig, Clinical & Pharmacol. & Physol. 13:39-46, 1986.
Tan et al., Cigarette Smoke Activates Guanylate Cyclase and Increases Guanosine 3', 5'-Monophosphate in Tissues, Science 198:934-936, 1977.
Maron et al., Cigarette Smoke Causes Acute Fluctuations in the Cyclic GMP Content of the Isolated Intact Lung, Respiration 43:39-44, 1984.
Heaslip et al., Co-Regulation of Tracheal Tone By Cyclic AMP-- and Cyclic GMP-Dependent Mechanisms, J. Pharmacl. & Experms. 243:1018-1026, 1987.
Moncada et al., Nitric Oxide: Physiology, Pathophysiology, and Pharmacology, Pharmacl. Reviews 91:109-141, 1991.
Kalant et al., Drugs and Respiratory System, Chapter 39 362-397, 1989.
Gilman et al., Vascular Effects of Cigarette Smoke in Isolated Pig Lungs, Am. Rev. Respir. Dis. 124:549-553, 1981.
Flenley, Today's Treatment of Airway Obstruction . . . and Tomorrow's?, Respiration 55:4-9, 1989.
Physicians'Desk Reference, pp. 969-971, 2322-2323, 668-670.
Edwards et al., Activation of Hepatic Guanylate Cyclase by Nitrosyl-Heme Complexes, Biomed. Pharmlgy. 30:2531-2538, 1981.
Garg et al., Nitric Oxide Generating Vasodilators Inhibit Mitogenesis and Proliferation of BALB/C 3T3 Fibroblasts by a Cyclic GMP-Independent Mechanism, Biochem. Biophysl. Re. Comm. 171:474-479, 1990.
Schmidt et al., Stimulation of Soluble Coronary Arterial Guanylate Cyclase by Sin-1, European J. Pharmaclgy. 122:75-79, 1986.
McNamara et al., Adenosine 3', 5' Monophosphate Formation by Preparation of Rat Liver Soluble Guanylate Cyclase . . . and Other Nitroso Compounds, Can. J. Physiol. Pharmacol. 58:1446-1456, 1980.
Ignarro, Biosynthesis and Metabolism of Endothelium-Derived Nitric Oxide, Annu. Rev. Pharmacol. Toxicol. 30:535-560, 1990.
Allen and Hanbury, Product Information Bulletin on Ventolin, 1990.
Boje et al., Endothelial Nitric Oxide Generating Enzyme(s) in the Bovine Aorta: Subcellular Location Location and Metabolic Characterization, Am. Soc. Pharmclgy. & Experm. Therapeutics 253:20-26, 1990.
Southern et al., Inhibition of Insulin Secretion by Interleukin-1.beta. and Tumor Necrosis Factor-.alpha. via an L-Arginine-Dependent Nitric Oxide Generating Mechanism, FEBS 276:42-44, 1990.
Garg et al., Nitric Oxide-Generating Vasodilators and 8-Bromo-Cyclic Guanosine Monophosphate Inhibit . . . Vascular Smooth Muscle Cells, J. Clin. Invest. 83:1774-1777, 1989.
Garg et al., Nitric Oxide-Generating Vasodilators Inhibit Mitogenesis and Proliferation of BALB/C 3T3 by a Cyclic GMP-Independent Mechanism, Biochem, Biophyl. Re. Comm. 171:474-479, 1990.
Brune et al., Activation of a Cytosolic ADP-Ribosyltransferase by Nitric Oxide-Generating Agents, J. Biol. Chem. 264:8455-8458, 1989.
Curran et al., Nitric Oxide and Nitric Oxide-Generating Compounds Inhibit Hepatocyte Protein Synthesis, FASEB J. 5:2085-2092, 1991.
Ignarro, Endothelium-Derived Nitric Oxide: Actions and Properties, FASEB J. 3:31-36, 1989.
Peckham, Physiologic Factors Affecting Pulmonary Artery Pressure in Infants with Persistent Pulmonary Hypertension, J. Ped. 6:1005-1010, 1978.
Zapol et al., Pulmonary Circulation During Adult Respiratory Distress Syndrome, Mercel Dekker, 241-273, 1985.
Fox et al., Pulmonary Hypertension in the Perinatal Aspiration Syndromes, Pediatrics 59:205-211, 1977.
Dworetz et al., Survival of Infants with Persistent Pulmonary Hypertension without Extracorporeal Membrane Oxygenation, Pediatrics 84:1-6, 1989.
Fishman, Pulmonary Hypertension and Cor Pulmonale, Chapter 64 pp. 999-1048.
Radermacher et al., Comparison of Ketanserin and Sodium Nitroprusside in Patients with Severe ARDS, Anesthesiology 68:152-157, 1988.
Vlahakes et al., The Pathophysiology of Failure in Acute Right Ventricular Hypertension: Hemodynamic and Biochemical Correlations, Circulation 63:87-95, 1981.
Ignarro et al., Endothelium-Derived Relaxing Factor Produced and Released from Artery and Vein is Nitric Oxide, Proc. Natl. Acad. Sci. USA 84:9265-9269, 1987.
Palmer et al., Nitric Oxide Release Accounts for the Biological Activity of Endothelium-Derived Relaxing Factor, Nature 327:524-526, 1987.
Ignarro, Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein, Dept. Pharmlgy. pp. 23-278.
Higgenbottam et al., Am. Rev. Resp. Dis. Suppl. 137:107, 1988.
Zapol et al., Pulmonary Hypertension in Severe Acute Respiratory Failure, N.E. J. Med. 296:476-480, 1977.
Meyer et al., Nitric Oxide (NO), A New Test Gas for Study of Alveolar-Capillary Diffusion, Eur. Respir. J. 2:494-496, 1989.
Hounam et al., particle Deposition pp. 125-156.
Archer et al., Comparison of the Hemodynamic Effects of Nitric Oxide and Endothelium-Dependent Vasodilators in Intact Lungs, J. Appl. Physiol. 68:735-747, 1990.
Furchgott et al., Endothelium-Derived Relaxing and Contracting Factors, FASEB J. 3:2007-2018, 1989.
Archer et
Alexander V.
Green Randall L.
The General Hospital Corporation
LandOfFree
Methods and devices for relaxing smooth muscle contractions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and devices for relaxing smooth muscle contractions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and devices for relaxing smooth muscle contractions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1781199